Sammy Karam - 17 Aug 2021 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
SENIOR VICE PRESIDENT
Signature
/s/ Sammy Karam by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
17 Aug 2021
Net transactions value
-$392,800
Form type
4
Filing time
19 Aug 2021, 18:29:39 UTC
Previous filing
05 Aug 2021
Next filing
28 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $607,200 +8,000 +35% $75.90 30,926 17 Aug 2021 Direct
transaction ABT Common shares without par value Sale $1,000,000 -8,000 -26% $125.00 22,926 17 Aug 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -8,000 -12% $0.000000 56,978 17 Aug 2021 Common Shares 8,000 $75.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3.

Remarks:

These transactions were made pursuant to a previously adopted plan complying with Rule 10b5-1(c).